Robert Baze­more inks one last deal for Epizyme — adding Chi­na to Tazverik's glob­al blue­print — be­fore head­ing out ...

4 years ago
Deals
China

As­traZeneca and Dai­ichi Sankyo con­tin­ue to flesh out En­her­tu plans, claim­ing win in ear­li­er breast can­cer line

4 years ago
R&D

Philip Mor­ris bags an­oth­er biotech as bid­ding war with Car­lyle over Vec­tura deal heats up

4 years ago
Deals

Most Fa­vored Na­tions rule for drug pric­ing: Gone, but not for­got­ten

4 years ago
Pharma

Biotech grieves over Tachi’s pass­ing; $3 tril­lion mi­rage?; Sanofi has a new Pompe drug; and more

4 years ago
Weekly

Sanofi wins ap­proval for Lu­mizyme suc­ces­sor, al­though up­take re­mains a mys­tery

4 years ago
Pharma
FDA+

Sen­ate Dems call to add Medicare drug price ne­go­ti­a­tions to rec­on­cil­i­a­tion bill; Cer­tara signs $310M buy­out of ...

4 years ago
News Briefing

Till­man Gern­gross steers a biotech uni­corn to Nas­daq, while an­oth­er com­pa­ny's IPO plans fiz­zle

4 years ago
Financing

FDA shoots down Spec­trum's neu­trope­nia drug, cit­ing man­u­fac­tur­ing is­sues

4 years ago
FDA+
Manufacturing

Court de­ci­sion push­es FDA to make his­tor­i­cal shift and reg­u­late bor­der­line drug/de­vice prod­ucts as de­vices

4 years ago
FDA+

Covid-19 roundup: Unit­ed be­comes first air­line to re­quire vac­cine for em­ploy­ees; New side ef­fects rec­om­mend­ed to J&J ...

4 years ago
Coronavirus

Ver­tex taps long­time com­mer­cial lead to fill two-year COO va­can­cy; Nan­cy Thorn­ber­ry set for dif­fer­ent role at ...

4 years ago
Peer Review

Fed­er­al cir­cuit up­holds Te­va-Glax­o­SmithK­line de­ci­sion, land­ing an­oth­er blow to 'skin­ny' la­bels

4 years ago
Pharma

Drug pric­ing dis­rup­tor EQRx makes the big leagues with $1.8B SPAC deal and a new CEO at the helm

4 years ago
Financing
Deals

FDA or­ders clin­i­cal hold on Aprea's p53 re­ac­ti­va­tor as strug­gling biotech pledges to ad­dress safe­ty con­cerns

4 years ago
FDA+

Chi­nese start­up with Mer­ck vet at the helm ac­quires rights to Oys­ter Point's eye dis­ease nasal spray

4 years ago
Deals
China

Courts to de­cide on whether drug­mak­ers have to sup­ply dis­count­ed drugs to un­lim­it­ed con­tract phar­ma­cies

4 years ago
Pharma

Gilead warns of coun­ter­feit HIV pills cir­cu­lat­ing in some US phar­ma­cies

4 years ago
Pharma

mGx M&A? Mod­er­na ex­ecs are lever­ag­ing their Covid cash on gene edit­ing, gene ther­a­py deals

4 years ago
Deals
Bioregnum

Dicer­na's RNAi drug shows 'in­con­sis­ten­t' re­sults in rare kid­ney dis­ease, tank­ing shares de­spite tri­al win

4 years ago
R&D

No­vavax shares dive on yet an­oth­er stum­ble in the hunt for an EUA, with FDA de­lay as US paus­es fund­ing

4 years ago
FDA+

With an as­sist from As­traZeneca, the sal­vage crew at Sier­ra bets an­oth­er $216M they can res­ur­rect an old Gilead JAK ...

4 years ago
Deals

Covid-19 man­u­fac­tur­ing roundup: EMA clears 2 New Eng­land man­u­fac­tur­ing sites for Covid-19 vac­cine scale up; ...

4 years ago
R&D

Room tem­per­a­ture ther­a­pies and bi­o­log­ics stored with lunch: New York drug im­porter hand­ed FDA warn­ing let­ter

4 years ago
Manufacturing
First page Previous page 654655656657658659660 Next page Last page
A service from the Financial Times